Author

Stéphanie Lagarde

Centre National de la Recherche ScientifiqueORCID 0009-0004-1817-3855Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

André BarucheliD· 1 shared Anne Quillet‐MaryiD· 1 shared Bastien GerbyiD· 1 shared Christine DidieriD· 1 shared Clémence RouzieriD· 1 shared Cyril BroccardoiD· 1 shared Élodie LaineyiD· 1 shared Emmanuelle ClappieriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

André BaruchelORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting glucocorticoid-induced CD20 activation in preclinical models of B-ALL

Jérémy Bigot, Mathieu Bouttier, Vincent Fregona, Clémence Rouzier, Manon Bayet, Sylvie Hébrard, Naïs Prade, Stéphanie Lagarde, Christine Didier, Laëtitia Largeaud, François Vergez, Anne Quillet‐Mary, Loïc Ysebaert, Cyril Broccardo, André Baruchel, , Bastien Gerby

This study identifies CD20 as an actionable target in B-ALL MRD using PDX models and single-cell RNA sequencing, showing anti-CD20 antibodies can eradicate drug-resistant cells.

bioRxiv · Dec 18, 2025 · PreprintCancer Biology